Compare Centrus Energy Corp (LEU) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centrus Energy Corp vs Recursion Pharmaceuticals Inc — how do they compare? Centrus Energy Corp trades at $190.48 (market cap $3.77B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Centrus Energy Corp is far larger — about 2.1× Recursion Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| LEU | RXRX | |
|---|---|---|
Market Cap | $3.77B | $1.81B |
Sector | Energy | Health |
52-Week High | $436.00 | $6.79 |
52-Week Low | $146.61 | $2.84 |
Enterprise Value | $3.08B | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Centrus Energy (LEU) trades at $191.37, up 7.49% in 24 hours, showing strong momentum amid bullish technical signals. Recent Q2 2026 earnings beat expectations with EPS of $0.77 versus $0.732 expected, though revenue growth is tempered by margin compression. The company secured a $900 million DOE contract and expanded its backlog to $4.5 billion, positioning it for long-term nuclear fuel demand. Analysts maintain a consensus buy rating with a $228.50 price target, reflecting optimism in its HALEU market dominance.
Outlook is positive due to government support and backlog visibility, but risks include high valuation (P/E 68.23), volatile cash flows, and execution challenges in scaling production. Investors should weigh growth potential against cost pressures and competitive dynamics in the nuclear sector.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centrus Energy Corp
Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.
Read more on LEU →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
